Evidence map›Paper›PMID 38787419›Full record

ReviewHuman genetics2024

Advances in long-read single-cell transcriptomics.

Pallawi Kumari, Manmeet Kaur, Kiran Dindhoria, Bruce Ashford, Shanika L Amarasinghe, Amarinder Singh Thind

Abstract readReview
In one paragraph

Review in Human genetics, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed.

  1. Review
  2. Article
  3. Review
  4. Review
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Long-Read Sequencing Reveals RNA Splicing Complexity in Human Diseases.Computational and structural biotechnology journal · 2026
    Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Pallawi KumariInstitute of Microbial Technology, Council of Scientific and Industrial Research, Chandigarh, India.
Manmeet KaurInstitute of Microbial Technology, Council of Scientific and Industrial Research, Chandigarh, India.
Kiran DindhoriaInstitute of Microbial Technology, Council of Scientific and Industrial Research, Chandigarh, India.
Bruce AshfordIllawarra Shoalhaven Local Health District (ISLHD), NSW Health, Wollongong, NSW, Australia.
Shanika L AmarasingheMonash Biomedical Discovery Institute, Monash University, Clayton, VIC, 3800, Australia.
Amarinder Singh ThindIllawarra Shoalhaven Local Health District (ISLHD), NSW Health, Wollongong, NSW, Australia. athind@uow.edu.au.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Long-read single-cell transcriptomics (scRNA-Seq) is revolutionizing the way we profile heterogeneity in disease. Traditional short-read scRNA-Seq methods are limited in their ability to provide complete transcript coverage, resolve isoforms, and identify novel transcripts. The scRNA-Seq protocols developed for long-read sequencing platforms overcome these limitations by enabling the characterization of full-length transcripts. Long-read scRNA-Seq techniques initially suffered from comparatively poor accuracy compared to short read scRNA-Seq. However, with improvements in accuracy, accessibility, and cost efficiency, long-reads are gaining popularity in the field of scRNA-Seq. This review details the advances in long-read scRNA-Seq, with an emphasis on library preparation protocols and downstream bioinformatics analysis tools.

Indexed as

Computational BiologyGene Expression ProfilingSingle-Cell AnalysisTranscriptomeAnimalsHigh-Throughput Nucleotide SequencingHumansSequence Analysis, RNA

Identifiers

PMID38787419
PMCPMC11485027

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.